Chappel; Scott C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chappel; Scott C..The latest application filed is for "mammalian metabolites of steroids".

Company Profile

0.8.6

Chappel; Scott C. - Milton MA
Chappel; Scott C. - Boston MA
Chappel; Scott C. - Jamaica Plain MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Mammalian Metabolites Of Steroids App 20170008920 - Chappel; Scott C. ; et al.	2017-01-12
Mammalian Metabolites Of Steroids App 20120282331 - Chappel; Scott C. ; et al.	2012-11-08
DNA coding for polypeptide fusion App 20100075402 - Campbell; Robert K. ; et al.	2010-03-25
Polypeptide fusion App 20090240039 - CAMPBELL; Robert K. ; et al.	2009-09-24
Homogeneity and secretion of a recombinant follicle stimulating hormone (FSH) in mammalian systems Grant 7,291,339 - Campbell , et al. November 6, 2	2007-11-06
Hybrid heterodimeric protein hormone and method of using same App 20040230034 - Campbell, Robert K. ; et al.	2004-11-18
Hybrid heterodimeric protein hormone comprising a TNF binding protein and a glycoprotein hormone subunit and method of using same Grant 6,663,867 - Campbell , et al. December 16, 2	2003-12-16
Hybrid heterodimeric protein hormone and method of using same App 20010014333 - Campbell, Robert K. ; et al.	2001-08-16
DNA encoding a hybrid heterodimeric protein Grant 6,194,177 - Campbell , et al. February 27, 2	2001-02-27
Cells with multiple altered epitopes on a surface antigen for use in transplantation Grant 6,096,537 - Chappel August 1, 2	2000-08-01
Cells with multiple altered epitopes on a surface antigen for use in transplantation Grant 5,679,340 - Chappel October 21, 1	1997-10-21
Heteropolymeric protein production methods Grant 5,674,711 - Kelton , et al. * October 7, 1	1997-10-07
Method for the modification of the expression characteristics of an endogenous gene of a given cell line Grant 5,272,071 - Chappel Dec	1993-12-21
Site-directed mutagenesis modified glycoprotein hormones Grant 5,260,421 - Chappel , et al. November 9, 1	1993-11-09

Company Registrations

SEC

0001551615

Chappel Scott C

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.